DTaP vaccine paediatric Tripacel - Sanofi
Alternative Names: Daptacel; DTaP-vaccine - Sanofi; TripacelLatest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Tetanus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Diphtheria in Sweden (IM)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Pertussis in Sweden (IM)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Tetanus in Sweden (IM)